Revesta (Sterling Knight Pharmaceuticals,LLC)
Welcome to the PulseAid listing for the Revesta drug offered from Sterling Knight Pharmaceuticals,LLC. This Vitamin D [Chemical/Ingredient],Vitamin D [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sterling Knight Pharmaceuticals,LLC |
NON-PROPRIETARY NAME: | Revesta |
SUBSTANCE NAME: | CHOLECALCIFEROL; FOLIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2016-10-13 |
END MARKETING DATE: | 0000-00-00 |
Revesta HUMAN PRESCRIPTION DRUG Details:
Item Description | Revesta from Sterling Knight Pharmaceuticals,LLC |
LABELER NAME: | Sterling Knight Pharmaceuticals,LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5750; 1([iU]/1; mg/1) |
START MARKETING DATE: | 2016-10-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69336-330_0206c671-3014-44b9-b3e8-4357f393452b |
PRODUCT NDC: | 69336-330 |
APPLICATION NUMBER: | |
Other CHOLECALCIFEROL; FOLIC ACID Pharmaceutical Manufacturers / Labelers: